mianserin has been researched along with Acute Confusional Senile Dementia in 13 studies
Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 79-year old female patient with Alzheimer's disease developed acute dystonia twelve hours after taking a single dose of mirtazapine 30 mg." | 7.73 | [Mirtazapine-induced dystonia in a patient with Alzheimer's disease]. ( Bouckaert, F; Peuskens, J; van den Bosch, S, 2006) |
| "Three patients with dementia and depression complicated by weight loss, insomnia, and anxiety were treated with mirtazapine at an outpatient memory loss clinic of a university hospital." | 7.71 | Mirtazapine for treatment of depression and comorbidities in Alzheimer disease. ( Brady, SR; Raji, MA, 2001) |
| "A 79-year old female patient with Alzheimer's disease developed acute dystonia twelve hours after taking a single dose of mirtazapine 30 mg." | 3.73 | [Mirtazapine-induced dystonia in a patient with Alzheimer's disease]. ( Bouckaert, F; Peuskens, J; van den Bosch, S, 2006) |
| "Three patients with dementia and depression complicated by weight loss, insomnia, and anxiety were treated with mirtazapine at an outpatient memory loss clinic of a university hospital." | 3.71 | Mirtazapine for treatment of depression and comorbidities in Alzheimer disease. ( Brady, SR; Raji, MA, 2001) |
| "Treatment with mirtazapine or placebo had no effect on cognitive and functional status as assessed by the Mini-Mental State Examination and the Katz scale, respectively." | 2.84 | Mirtazapine does not improve sleep disorders in Alzheimer's disease: results from a double-blind, placebo-controlled pilot study. ( Camargos, EF; Louzada, LL; Naves, JO; Nóbrega, OT; Quintas, JL; Scoralick, FM, 2017) |
| "The prevalence of insomnia increases with age and affects up to 35% of community-dwelling adults with dementia." | 2.45 | Non-pharmacologic treatment of insomnia in persons with dementia. ( Darvishi, R; Kunik, ME; Shub, D, 2009) |
| "A 75-years-old man with Alzheimer's disease, treated with the cholinesterase inhibitor donepezil for 14 months, was scheduled for left colectomy under general anesthesia." | 1.32 | [Interaction of donepezil and muscular blockers in Alzheimer's disease]. ( Demartini Ferrari, A; Roca de Togores López, A; Sánchez Morillo, J, 2003) |
| "Of these disorders, depression is the most accessible of these to pharmacological treatment; agitation, however, raises the institutional problem." | 1.28 | Psychiatrists and Alzheimer's disease. ( Cazas, A; Flame, E; Ginestet, D, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 7 (53.85) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Scoralick, FM | 1 |
| Louzada, LL | 1 |
| Quintas, JL | 1 |
| Naves, JO | 1 |
| Camargos, EF | 1 |
| Nóbrega, OT | 1 |
| Kálmán, J | 2 |
| Shub, D | 1 |
| Darvishi, R | 1 |
| Kunik, ME | 1 |
| Brodaty, H | 1 |
| Banerjee, S | 1 |
| Hellier, J | 1 |
| Dewey, M | 1 |
| Romeo, R | 1 |
| Ballard, C | 1 |
| Baldwin, R | 1 |
| Bentham, P | 1 |
| Fox, C | 1 |
| Holmes, C | 1 |
| Katona, C | 1 |
| Knapp, M | 1 |
| Lawton, C | 1 |
| Lindesay, J | 1 |
| Livingston, G | 1 |
| McCrae, N | 1 |
| Moniz-Cook, E | 1 |
| Murray, J | 1 |
| Nurock, S | 1 |
| Orrell, M | 1 |
| O'Brien, J | 1 |
| Poppe, M | 1 |
| Thomas, A | 1 |
| Walwyn, R | 1 |
| Wilson, K | 1 |
| Burns, A | 1 |
| Sepehry, AA | 1 |
| Lee, PE | 1 |
| Hsiung, GY | 1 |
| Jacova, C | 1 |
| Ahmed, A | 1 |
| Sánchez Morillo, J | 1 |
| Demartini Ferrari, A | 1 |
| Roca de Togores López, A | 1 |
| Palotás, A | 1 |
| Puskás, LG | 1 |
| Kitajka, K | 1 |
| Palotás, M | 1 |
| Molnár, J | 1 |
| Pákáski, M | 1 |
| Janka, Z | 1 |
| Penke, B | 1 |
| van den Bosch, S | 1 |
| Bouckaert, F | 1 |
| Peuskens, J | 1 |
| Raji, MA | 1 |
| Brady, SR | 1 |
| Haupt, M | 1 |
| Cazas, A | 1 |
| Flame, E | 1 |
| Ginestet, D | 1 |
3 reviews available for mianserin and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
[Genomical and metabolomical abnormalities in Alzheimer disease and in experimental models].
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Antidepressive Agents; Apolipoprotein E4 | 2008 |
Non-pharmacologic treatment of insomnia in persons with dementia.
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Antidepressive Agents, Tricyclic; Circadian Rhyth | 2009 |
Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antidepressive Agents; Dementia; Depressive Disorder; Do | 2011 |
2 trials available for mianserin and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Mirtazapine does not improve sleep disorders in Alzheimer's disease: results from a double-blind, placebo-controlled pilot study.
Topics: Actigraphy; Aged; Aged, 80 and over; Alzheimer Disease; Antidepressive Agents, Tricyclic; Brazil; Do | 2017 |
Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antidepressive Agents; Dementia; Depressive Disorder; Do | 2011 |
9 other studies available for mianserin and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Antidepressant treatment in Alzheimer's disease.
Topics: Aged, 80 and over; Alzheimer Disease; Antidepressive Agents; Dementia; Depressive Disorder; Double-B | 2011 |
Stay the course--is it justified?
Topics: Alzheimer Disease; Antidepressive Agents; Dementia; Depressive Disorder; Female; Humans; Male; Menta | 2012 |
Neutropenia associated with mirtazapine use: is a drop in the neutrophil count in a symptomatic older adults a cause for concern?
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antidepressive Agents, Tricyclic; Depression; Female; Hu | 2002 |
[Interaction of donepezil and muscular blockers in Alzheimer's disease].
Topics: Acetylcholine; Aged; Alzheimer Disease; Anesthesia, General; Atracurium; Cholinesterase Inhibitors; | 2003 |
Altered response to mirtazapine on gene expression profile of lymphocytes from Alzheimer's patients.
Topics: Aged; Alzheimer Disease; Antidepressive Agents, Tricyclic; Female; Gene Expression Profiling; Humans | 2004 |
[Mirtazapine-induced dystonia in a patient with Alzheimer's disease].
Topics: Acute Disease; Adrenergic alpha-Antagonists; Aged; Alzheimer Disease; Dystonia; Female; Humans; Mian | 2006 |
Mirtazapine for treatment of depression and comorbidities in Alzheimer disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antidepressive Agents, Tricyclic; Comorbidity; Depressio | 2001 |
Depression in Alzheimer's disease significantly improved under treatment with mianserine.
Topics: Aged; Alzheimer Disease; Depression; Female; Humans; Mianserin | 1991 |
Psychiatrists and Alzheimer's disease.
Topics: Alzheimer Disease; Circadian Rhythm; Cognition; Dementia; Depression; Diagnosis, Differential; Human | 1989 |